Primary sclerosing cholangitis and malignancy

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 6, 2011, Pages 753-764

  Boberg, Kirsten Muri ^a   Lind, Guro E ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cholangiocarcinoma; Colorectal cancer; Epigenetic markers; Gallbladder cancer; Inflammatory bowel disease; Liver transplantation; Primary sclerosing cholangitis; PSC; Tumour markers

Indexed keywords

BINDING PROTEIN; CA 19-9 ANTIGEN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKERATIN 19 FRAGMENT; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; INTERLEUKIN 6; MAC 2 BINDING PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 5; MUCIN 4; MUCIN 5AC; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; TRYPSINOGEN; TRYPSINOGEN 2; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VASCULOTROPIN;

ARTICLE; BILE DUCT CARCINOMA; BILIARY DYSPLASIA; BILIARY TRACT ENDOSCOPY; CANCER CHEMOTHERAPY; CANCER STAGING; CHOLECYSTECTOMY; CHROMOSOME ABERRATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIGITAL IMAGE ANALYSIS; DNA METHYLATION; DYSPLASIA; EARLY DIAGNOSIS; END STAGE LIVER DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GALLBLADDER CANCER; GALLBLADDER CARCINOMA; GALLBLADDER POLYP; GALLBLADDER TUMOR; GENE TARGETING; GENETIC VARIABILITY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIMARY SCLEROSING CHOLANGITIS; PROTEOMICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRASOUND;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; DNA METHYLATION; GALLBLADDER NEOPLASMS; HUMANS; LIVER NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 82255165447     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.10.002     Document Type: Article

References (79)

1. A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, L. Lööf, and A. Danielsson Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 2002 321 327 (Pubitemid 34194790)
2. U. Broomé, R. Olsson, L. Lööf, G. Bodemar, R. Hultcrantz, and A. Danielsson Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 1996 610 615 (Pubitemid 26111384)
3. K.M. Boberg, A. Bergquist, S. Mitchell, A. Pares, F. Rosina, and U. Broomé Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 2002 1205 1211 (Pubitemid 35189610)
4. J.J. Tischendorf, H. Hecker, M. Krüger, M.P. Manns, and P.N. Meier Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study Am J Gastroenterol 102 2007 107 114 (Pubitemid 46072050)
5. K. Burak, P. Angulo, T.M. Pasha, K. Egan, J. Petz, and K.D. Lindor Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 2004 523 526 (Pubitemid 38524134)
6. J. Fevery, C. Verslype, G. Lai, R. Aerts, and W. Van Steenbergen Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis Dig Dis Sci 52 2007 3123 3135 (Pubitemid 47512534)
7. P. Charatcharoenwitthaya, F.B. Enders, K.C. Halling, and K.D. Lindor Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis Hepatology 48 2008 1106 1117
8. M.M. Claessen, F.P. Vleggaar, K.M. Tytgat, P.D. Siersema, and H.R. van Buuren High lifetime risk of cancer in primary sclerosing cholangitis J Hepatol 50 2009 158 164
9. B. Blechacz, and G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321 (Pubitemid 351975555)
10. J. Fevery, and C. Verslype An update on cholangiocarcinoma associated with primary sclerosing cholangitis Curr Opin Gastroenterol 26 2010 236 245
11. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
12. M. Forsbring, E.S. Vik, B. Dalhus, T.H. Karlsen, A. Bergquist, and E. Schrumpf Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma Carcinogenesis 30 2009 1147 1154
13. E. Melum, T.H. Karlsen, E. Schrumpf, A. Bergquist, E. Thorsby, and K.M. Boberg Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms Hepatology 47 2008 90 96 (Pubitemid 351171045)
14. W.L. Campbell, J.V. Ferris, B.L. Holbert, F.L. Thaete, and R.L. Baron Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging Radiology 207 1998 41 50 (Pubitemid 28168665)
15. G.I. Kirchner, J.J. Tischendorf, J. Bleck, S. Wagner, M. Caselitz, and J. Klempnauer Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma Scand J Gastroenterol 43 2008 1366 1370
16. H. Prytz, S. Keiding, E. Björnsson, U. Broomé, S. Almer, and M. Castedal Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation Hepatology 44 2006 1572 1580 (Pubitemid 44953662)
17. EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
18. N.S. Awadallah, Y.K. Chen, C. Piraka, M.R. Antillon, and R.J. Shah Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol 101 2006 284 291 (Pubitemid 43381669)
19. J.J. Tischendorf, P.N. Meier, A. Schneider, M.P. Manns, and M. Krüger Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis Scand J Gastroenterol 42 2007 1011 1017 (Pubitemid 47037125)
20. J.T. Lewis, J.A. Talwalkar, C.B. Rosen, T.C. Smyrk, and S.C. Abraham Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma Am J Surg Pathol 34 2010 27 34
21. K.M. Boberg, P. Jebsen, O.P. Clausen, A. Foss, L. Aabakken, and E. Schrumpf Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 45 2006 568 574 (Pubitemid 44307380)
22. L.E. Moreno Luna, B. Kipp, K.C. Halling, T.J. Sebo, W.K. Kremers, and L.R. Roberts Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures Gastroenterology 131 2006 1064 1072 (Pubitemid 44498705)
23. S.Y. Bangarulingam, E. Bjornsson, F. Enders, E.G. Barr Fritcher, G. Gores, and K.C. Halling Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis Hepatology 51 2010 174 180
24. D. Alvaro Serum and bile biomarkers for cholangiocarcinoma Curr Opin Gastroenterol 25 2009 279 284
25. C. Levy, J. Lymp, P. Angulo, G.J. Gores, N. LaRusso, and K.D. Lindor The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis Dig Dis Sci 50 2005 1734 1740 (Pubitemid 41203674)
26. E. Sinakos, A.K. Saenger, J. Keach, W.R. Kim, and K.D. Lindor Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma Clin Gastroenterol Hepatol 9 2011 434 439
27. M. Lempinen, H. Isoniemi, H. Mäkisalo, A. Nordin, L. Halme, and J. Arola Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures J Hepatol 47 2007 677 683 (Pubitemid 47503427)
28. G.K. Bonney, R.A. Craven, R. Prasad, A.F. Melcher, P.J. Selby, and R.E. Banks Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol 9 2008 149 158 (Pubitemid 351150126)
29. T.O. Lankisch, J. Metzger, A.A. Negm, K. Vosskuhl, E. Schiffer, and J. Siwy Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis Hepatology 53 2011 875 884
30. N. Albiin, I.C. Smith, U. Arnelo, B. Lindberg, A. Bergquist, and B. Dolenko Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis Acta Radiol 49 2008 855 862
31. C.B. Rosen, and D.M. Nagorney Cholangiocarcinoma complicating primary sclerosing cholangitis Semin Liver Dis 11 1991 26 30
32. M. Kaya, P.C. de Groen, P. Angulo, D.M. Nagorney, L.L. Gunderson, and G.J. Gores Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo clinic experience Am J Gastroenterol 96 2001 1164 1169 (Pubitemid 32319155)
33. S.A. Ahrendt, H.A. Pitt, A. Nakeeb, A.S. Klein, K.D. Lillemoe, and A.N. Kalloo Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis J Gastrointest Surg 3 1999 357 367
34. S. Friman Cholangiocarcinoma - current treatment options Scand J Surg 100 2011 30 34
35. K. Bjoro, and E. Schrumpf Liver transplantation for primary sclerosing cholangitis J Hepatol 40 2004 570 577 (Pubitemid 38367777)
36. S. Friman, A. Foss, H. Isoniemi, M. Olausson, K. Höckerstedt, and S. Yamamoto Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results Scand J Gastroenterol 46 2011 370 375
37. J.K. Heimbach, G.J. Gores, M.G. Haddock, S.R. Alberts, R. Pedersen, and W. Kremers Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma Transplantation 82 2006 1703 1707 (Pubitemid 46035655)
38. D. Sudan, A. DeRoover, S. Chinnakotla, I. Fox, B. Shaw Jr., and T. McCashland Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma Am J Transplant 2 2002 774 779 (Pubitemid 36342621)
39. K.N. Lazaridis, and G.J. Gores Primary sclerosing cholangitis and cholangiocarcinoma Semin Liver Dis 26 2006 42 51 (Pubitemid 43320726)
40. J. Valle, H. Wasan, D.H. Palmer, D. Cunningham, A. Anthoney, and A. Maraveyas Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 2010 1273 1281
41. N. Razumilava, and G.J. Gores Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on J Hepatol 54 2011 577 578
42. D.J. Brandt, R.L. MacCarty, J.W. Charboneau, N.F. LaRusso, R.H. Wiesner, and J. Ludwig Gallbladder disease in patients with primary sclerosing cholangitis AJR Am J Roentgenol 150 1988 571 574 (Pubitemid 18075395)
43. D.C. Buckles, K.D. Lindor, N.F. LaRusso, L.M. Petrovic, and G.J. Gores In primary sclerosing cholangitis, gallbladder polyps are frequently malignant Am J Gastroenterol 97 2002 1138 1142 (Pubitemid 34478111)
44. J.T. Lewis, J.A. Talwalkar, C.B. Rosen, T.C. Smyrk, and S.C. Abraham Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence Am J Surg Pathol 31 2007 907 913 (Pubitemid 47165145)
45. K. Said, H. Glaumann, and A. Bergquist Gallbladder disease in patients with primary sclerosing cholangitis J Hepatol 48 2008 598 605
46. D.M. Harnois, G.J. Gores, J. Ludwig, J.L. Steers, N.F. LaRusso, and R.H. Wiesner Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol 27 1997 512 516 (Pubitemid 27390899)
47. J.E. Baars, C.W. Looman, E.W. Steyerberg, R. Beukers, A.C. Tan, and B.L. Weusten The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study Am J Gastroenterol 106 2011 319 328
48. U. Broomé, R. Löfberg, B. Veress, and L.S. Eriksson Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential Hepatology 22 1995 1404 1408
49. K. Shetty, L. Rybicki, A. Brzezinski, W.D. Carey, and B.A. Lashner The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis Am J Gastroenterol 94 1999 1643 1649 (Pubitemid 29260459)
50. E.V. Loftus Jr., G.C. Harewood, C.G. Loftus, W.J. Tremaine, W.S. Harmsen, and A.R. Zinsmeister PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 2005 91 96 (Pubitemid 40007225)
51. U. Broomé, and A. Bergquist Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer Semin Liver Dis 26 2006 31 41 (Pubitemid 43320725)
52. L. Lindström, A. Lapidus, A. Öst, and A. Bergquist Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis Dis Colon Rectum 54 2011 1392 1397
53. R.M. Soetikno, O.S. Lin, P.A. Heidenreich, H.S. Young, and M.O. Blackstone Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis Gastrointest Endosc 56 2002 48 54 (Pubitemid 41115048)
54. K.K. Jørgensen, K. Grzyb, K.E. Lundin, O.P. Clausen, G. Aamodt, and E. Schrumpf Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients Inflamm Bowel Dis 2011 10.1002/ibd.21699
55. S. Brackmann, S.N. Andersen, G. Aamodt, F. Langmark, O.P. Clausen, and E. Aadland Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease Scand J Gastroenterol 2008 1 10
56. T.H. Karlsen, A. Franke, E. Melum, A. Kaser, J.R. Hov, and T. Balschun Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
57. M.M. Claessen, M.W. Lutgens, H.R. van Buuren, B. Oldenburg, P.C. Stokkers, and C.J. van der Woude More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis Inflamm Bowel Dis 15 2009 1331 1336
58. E.W. Thackeray, P. Charatcharoenwitthaya, D. Elfaki, E. Sinakos, and K.D. Lindor Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis Clin Gastroenterol Hepatol 9 2011 52 56
59. I. Dvorchik, M. Subotin, A.J. Demetris, J.J. Fung, T.E. Starzl, and S. Wieand Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis Hepatology 35 2002 380 384 (Pubitemid 34106378)
60. A. Vera, B.K. Gunson, V. Ussatoff, P. Nightingale, D. Candinas, and S. Radley Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis Transplantation 75 2003 1983 1988 (Pubitemid 36793279)
61. E.V. Loftus Jr., H.I. Aguilar, W.J. Sandborn, W.J. Tremaine, R.A. Krom, and A.R. Zinsmeister Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation Hepatology 27 1998 685 690 (Pubitemid 28103543)
62. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2004 143 153 (Pubitemid 38198742)
63. P.W. Laird The power and the promise of DNA methylation markers Nat Rev Cancer 3 2003 253 266 (Pubitemid 37328861)
64. S.A. Ahrendt, C.F. Eisenberger, L. Yip, A. Rashid, J.T. Chow, and H.A. Pitt Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma J Surg Res 84 1999 88 93 (Pubitemid 29391606)
65. H. Isomoto Epigenetic alterations associated with cholangiocarcinoma (review) Oncol Rep 22 2009 227 232
66. B.H. Kim, N.Y. Cho, M. Choi, S. Lee, J.J. Jang, and G.H. Kang Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas Arch Pathol Lab Med 131 2007 923 930 (Pubitemid 46906384)
67. I. Tischoff, A. Markwarth, H. Witzigmann, D. Uhlmann, J. Hauss, and A. Mirmohammadsadegh Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors Int J Cancer 115 2005 684 689 (Pubitemid 40776690)
68. B. Klump, C.J. Hsieh, S. Dette, K. Holzmann, R. Kiebetalich, and M. Jung Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease Clin Cancer Res 9 2003 1773 1778 (Pubitemid 36554603)
69. M.S. Kim, J. Lee, and D. Sidransky DNA methylation markers in colorectal cancer Cancer Metastasis Rev 29 2010 181 206
70. T. Ahlquist, G.E. Lind, V.L. Costa, G.I. Meling, M. Vatn, and G.S. Hoff Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers Mol Cancer 7 2008 94
71. M. Zitt, M. Zitt, and H.M. Muller DNA methylation in colorectal cancer-impact on screening and therapy monitoring modalities? Dis Markers 23 2007 51 71 (Pubitemid 46333641)
72. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
73. C.J. Hsieh, B. Klump, K. Holzmann, F. Borchard, M. Gregor, and R. Porschen Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res 58 1998 3942 3945 (Pubitemid 28405652)
74. Z. Lin, J. Hegarty, J. Cappel, W. Yu, X. Chen, and P. Faber Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease Clin Genet 80 2011 59 67
75. M. Esteller, P.G. Corn, S.B. Baylin, and J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229 (Pubitemid 32695003)
76. G.E. Lind, T. Ahlquist, and R.A. Lothe DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors Gastroenterology 132 2007 1631 1632 (Pubitemid 46656256)
77. G.E. Lind, C. Raiborg, S.A. Danielsen, T.O. Rognum, E. Thiis-Evensen, and G. Hoff SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis Oncogene 2011
78. H. Zou, J.J. Harrington, A.M. Shire, R.L. Rego, L. Wang, and M.E. Campbell Highly methylated genes in colorectal neoplasia: implications for screening Cancer Epidemiol Biomarkers Prev 16 2007 2686 2696 (Pubitemid 351196325)
79. T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, and J. Distler Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clin Chem 55 2009 1337 1346